iodine povacrylex
Trade name: DuraPrep Surgical
Small moleculeapproved
Approved
Sep 29, 2006
Clinical trial activity
10 trials · 13 clinical orgs · 2 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
2
Phase 4
1
Earliest trial started Jan 31, 2010 (NCT01105195)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetOTHER
Skin preparation/antiseptic, oxidising agent
- UnclearUnclear
Unclear unclear
Combination products
duraprep
with isopropyl alcohol
Approval history
- approvedSep 29, 2006
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Over the Counter
Oral
No
Parenteral
No
Topical
Yes
Sources
- ChEMBLCHEMBL1201721 ↗
Also known as
- citrate - isopropyl alcohol - methylene blue - parabens
- citrate, isopropyl alcohol, methylene blue, parabens drug combination
- duraprep copolymer
- iodine povacrylex
- iodine povacrylex
- iodine povacrylex
- iodine povacrylex
- zuraprep
- zuraprep
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03859908 | Phase 4 | Apr 5, 2019 | Universidad del Salvador |
| NCT03523962 | Phase 3 | Aug 21, 2018 | McMaster University, Patient-Centered Outcomes Research Institute, University of Maryland |
| NCT02578771 | Phase 3 | Oct 1, 2015 | MicroBioTest, Zurex Pharma, Inc. |
| NCT02296645 | Phase 2 | Nov 1, 2014 | MicroBioTest, Zurex Pharma, Inc. |
| NCT03393819 | N/A | Oct 29, 2014 | Lakehead University, Northern Ontario School of Medicine, Thunder Bay Regional Health Sciences Centre |
| NCT02221232 | Phase 2 | Aug 1, 2014 | Bio-Science Laboratories, Zurex Pharma, Inc. |
| NCT02160587 | Phase 1 | Jul 1, 2014 | Bio-Science Laboratories, Zurex Pharma, Inc. |
| NCT02160574 | Phase 1 | Jun 1, 2014 | Bio-Science Laboratories, Zurex Pharma, Inc. |
| NCT01233050 | N/A | Dec 1, 2010 | 3M, University of Pennsylvania |
| NCT01105195 | N/A | Jan 31, 2010 | 3M, Northwestern University |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (13)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zurex Pharma, Inc. | For profit | 5 | 5 | 3 | 2014 |
| Bio-Science Laboratories | For profit | 3 | 0 | 2 | 2014 |
| 3M | For profit | 2 | 0 | 1 | 2010 |
| MicroBioTest | For profit | 2 | 0 | 2 | 2014 |
| Lakehead University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| McMaster University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Northern Ontario School of Medicine | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Northwestern University | Academic/Hospital | 1 | 1 | 1 | 2010 |
| Patient-Centered Outcomes Research Institute | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Thunder Bay Regional Health Sciences Centre | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Universidad del Salvador | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Maryland | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2010 |
13 organizations
Page 1 / 1